Analystreport

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $27.00 price target on the stock.

Avadel Pharmaceuticals plc - Ordinary Share  (AVDL) 
Last avadel pharmaceuticals plc - ordinary share earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: avadel.com